Clinical Trials

Marijuana Abuse, Prostatic Neoplasms

NCT06117059 2026-01-12

PRECISION

Prostatic Neoplasms

NCT07308990 2025-12-30

Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer

800 enrolled

Prostatic Neoplasms

NCT01089387 2025-12-04

INSTIN

Phase 1/2 Completed

18 enrolled

Phase NA Active not recruiting

Erectile Dysfunction, Prostatic Neoplasms

NCT06238596 2025-10-03

ReCaP

38 enrolled

Prostatic Neoplasms

NCT07156747 2025-09-05

TRUS

223 enrolled

Phase NA Not yet recruiting

Anxiety Disorders, Prostatic Neoplasms

NCT06915909 2025-04-08

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

40 enrolled

Adenocarcinoma, Pain, Pain, Postoperative, Prostatic Neoplasms

NCT06565247 2025-03-04

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

Phase 3 Recruiting

60 enrolled

Prostatic Neoplasms

NCT06766526 2025-02-24

ISAC

180 enrolled

Phase 1 Active not recruiting

Anxiety Disorders, Sleep Initiation and Maintenance Disorders, Neoplasms, Prostatic Neoplasms

NCT05917860 2025-02-17

NeoADT-TULSA

15 enrolled

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT06756334 2025-01-03

Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Prostatic Neoplasms

NCT03350529 2024-11-25

HIFU-PRO

87 enrolled

Phase EARLY_PHASE1 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms

NCT06462495 2024-06-17

Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT06462508 2024-06-17

Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Prostatic Neoplasms

NCT06313775 2024-03-15

Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy

18 enrolled

Prostatic Neoplasms

NCT05326282 2024-02-28

ERUP

Prostatic Neoplasms

NCT05587192 2024-02-12

RPWPB

57 enrolled

Disease, Prostatic Neoplasms

NCT06219746 2024-01-23

99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer

320 enrolled

Prostatic Neoplasms

NCT06119438 2023-11-07

Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy

120 enrolled

Anxiety Disorders, Prostatic Neoplasms

NCT06001619 2023-08-21

PROMED

Phase 4 Recruiting

Phase EARLY_PHASE1 Unknown

Prostatic Hyperplasia, Prostatic Neoplasms

NCT05955677 2023-07-21

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Phase 2/3 Active not recruiting

Prostatic Neoplasms

NCT00268476 2023-04-18

STAMPEDE

11,992 enrolled

Prostatic Neoplasms

NCT04500080 2022-10-19

PCa_Ex

5 enrolled

Motor Activity, Prostatic Neoplasms

NCT05427864 2022-06-28

Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging

47 enrolled

Prostatic Neoplasms

NCT03537391 2022-05-04

PROSTAGE

80 enrolled

Prostatic Neoplasms

NCT04287088 2021-11-23

multiIMPROD2

600 enrolled

Prostatic Neoplasms

NCT03876912 2021-04-13

ADTPSMA2

35 enrolled

Prostatic Neoplasms

NCT04523896 2020-08-24

BRAchySABR

Phase 2 Unknown

50 enrolled

Prostatic Neoplasms

NCT04064047 2020-01-13

Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided Biopsy

284 enrolled

Pain, Prostatic Neoplasms

NCT04159090 2019-11-12

Head- to Head Comparison of [68Ga]Ga-PSMA-11 With [18F]PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard

20 enrolled

Prostatic Neoplasms

NCT04158414 2019-11-08

Applying PET/MR in Oncology - a Prospective Project

GastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcoma

500 enrolled

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lymphoma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT04154280 2019-11-06

Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer

50 enrolled

Prostatic Neoplasms

NCT04116086 2019-10-04

Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage

50 enrolled

Prostatic Neoplasms

NCT03025633 2019-07-15

Explaining the Invisible Using the PEARL System

155 enrolled

Prostatic Neoplasms

NCT01006395 2019-07-05

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Phase 2/3 Completed

64 enrolled

Insulin Resistance, Prostatic Neoplasms

NCT03709485 2018-10-17

Evaluation of Gut Microbiome in Patients With Prostate Cancer

150 enrolled

Prostatic Neoplasms

NCT02241122 2018-04-18

Multi-IMPROD

350 enrolled

Prostatic Neoplasms

NCT02388126 2018-04-18

PROMANEG

150 enrolled

Prostatic Neoplasms

NCT03313726 2017-10-18

ADTPSMA

Prostatic Neoplasms

NCT02934685 2016-11-18

IG-VMAT for Localized Prostate Cancer

Phase 3 Unknown

60 enrolled

Prostatic Neoplasms

NCT02002455 2016-10-21

Flucipro

Phase 2 Completed

26 enrolled

Prostatic Neoplasms

NCT02844829 2016-07-26

IMPROD2_0

200 enrolled

Prostatic Neoplasms

NCT01864135 2016-01-21

IMPROD

175 enrolled

Prostatic Neoplasms

NCT01100866 2014-03-11

Study of POMELLA™ Extract to Treat Prostate Cancer

Phase NA Terminated

1 enrolled

Prostatic Neoplasms

NCT00489905 2013-10-23

Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

24 enrolled

Prostatic Neoplasms

NCT00657982 2009-01-21

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Phase 2 Unknown

15 enrolled